Peng Yang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Venues

Journal of medicinal chemistry

Future medicinal chemistry

Cancers

Nature communications

China Pharmaceutical University

Tsinghua University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Mar 08 2018

China

Professor/Associate Chair :: Medicinal Chemistry

Bioduro Aug 01 2017 - Feb 28 2018

China

Associate Director :: Medicinal Chemistry

University of Pittsburgh Dec 01 2015 - Jul 31 2017

United States

Assistant Professor :: Medicinal Chemistry

Education History

Tsinghua University Aug 01 2005 - Jul 31 2008

China

PHD :: Peking Union Medical College

Peking Union Medical College Press Aug 01 2002 - Jul 31 2005

China

MSC

Shandong University Aug 01 1998 - Jul 31 2002

China

BSC

Publications

Yasheng Zhu, Xiuquan Ye, Yuxing Wu, Hao Shen, Zeyu Cai, Fei Xia, Wenjian Min, Yi Hou, Liping Wang, Xiao Wang, Yibei Xiao, Peng Yang
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation. Journal of medicinal chemistry (2024)
Mingming Zheng, Xiao-Yu Zhang, Weijiao Chen, Fei Xia, Huanaoyu Yang, Kai Yuan, Peng Yang
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy. Future medicinal chemistry 16 (4) (2024)
Mingming Zheng, Xiao-Yu Zhang, Weijiao Chen, Fei Xia, Huanaoyu Yang, Kai Yuan, Peng Yang
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy. Future medicinal chemistry (2024)
Mingming Zheng, Xiao-Yu Zhang, Weijiao Chen, Fei Xia, Huanaoyu Yang, Kai Yuan, Peng Yang
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy. Future medicinal chemistry 16 (4) (2024)
Wenjian Min, Huanaoyu Yang, Dawei Wang, Chunling Chen, Yanyin Wang, Yi Hou, Yasheng Zhu, Chengliang Sun, Xiao Wang, Kai Yuan, Peng Yang
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment. Journal of medicinal chemistry 67 (14) (2024)
Chengliang Sun, Yuling He, Gefei Wang, Guoyu Zhang, Yu Zhang, Hao Shen, Lingrong Hu, Yanze Sun, Binjian Jiang, Xiao Wang, Kai Yuan, Wenjian Min, Liping Wang, Haopeng Sun, Yibei Xiao, Peng Yang
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors. Journal of medicinal chemistry 67 (5) (2024)
Yasheng Zhu, Xiuquan Ye, Yuxing Wu, Hao Shen, Zeyu Cai, Fei Xia, Wenjian Min, Yi Hou, Liping Wang, Xiao Wang, Yibei Xiao, Peng Yang
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation. Journal of medicinal chemistry 67 (9) (2024)
Chengliang Sun, Yuling He, Gefei Wang, Guoyu Zhang, Yu Zhang, Hao Shen, Lingrong Hu, Yanze Sun, Binjian Jiang, Xiao Wang, Kai Yuan, Wenjian Min, Liping Wang, Haopeng Sun, Yibei Xiao, Peng Yang
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors. Journal of medicinal chemistry 67 (5) (2024)
Wenjian Min, Huanaoyu Yang, Dawei Wang, Chunling Chen, Yanyin Wang, Yi Hou, Yasheng Zhu, Chengliang Sun, Xiao Wang, Kai Yuan, Peng Yang
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment. Journal of medicinal chemistry 67 (14) (2024)
Wenjian Min, Huanaoyu Yang, Dawei Wang, Chunling Chen, Yanyin Wang, Yi Hou, Yasheng Zhu, Chengliang Sun, Xiao Wang, Kai Yuan, Peng Yang
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment. Journal of medicinal chemistry 67 (14) (2024)
Mingming Zheng, Xiao-Yu Zhang, Weijiao Chen, Fei Xia, Huanaoyu Yang, Kai Yuan, Peng Yang
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy. Future medicinal chemistry 16 (4) (2024)
Wenjian Min, Huanaoyu Yang, Dawei Wang, Chunling Chen, Yanyin Wang, Yi Hou, Yasheng Zhu, Chengliang Sun, Xiao Wang, Kai Yuan, Peng Yang
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment. Journal of medicinal chemistry (2024)
Chengliang Sun, Yuling He, Gefei Wang, Guoyu Zhang, Yu Zhang, Hao Shen, Lingrong Hu, Yanze Sun, Binjian Jiang, Xiao Wang, Kai Yuan, Wenjian Min, Liping Wang, Haopeng Sun, Yibei Xiao, Peng Yang
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors. Journal of medicinal chemistry (2024)
Lei Wang, Tianyu Sun, Zhenqi Wang, Hui Liu, Weimin Qiu, Xu Tang, Huanchao Guo, Peng Yang, Yao Chen, Haopeng Sun
Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer's Disease. ACS chemical neuroscience (2023)
Yasheng Zhu, Xiuquan Ye, Hao Shen, Jiaxing Li, Zeyu Cai, Wenjian Min, Yi Hou, Haojie Dong, Yuxing Wu, Liping Wang, Xiao Wang, Yibei Xiao, Peng Yang
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance. Journal of medicinal chemistry (2023)
Kai Yuan, Hongtao Shen, Mingming Zheng, Fei Xia, Qiannan Li, Weijiao Chen, Minghui Ji, Huanaoyu Yang, Xujie Zhuang, Zeyu Cai, Wenjian Min, Xiao Wang, Yibei Xiao, Peng Yang
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer. Journal of medicinal chemistry 66 (6) (2023)
Kai Yuan, Hongtao Shen, Mingming Zheng, Fei Xia, Qiannan Li, Weijiao Chen, Minghui Ji, Huanaoyu Yang, Xujie Zhuang, Zeyu Cai, Wenjian Min, Xiao Wang, Yibei Xiao, Peng Yang
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer. Journal of medicinal chemistry (2023)
Kai Yuan, Hongtao Shen, Mingming Zheng, Fei Xia, Qiannan Li, Weijiao Chen, Minghui Ji, Huanaoyu Yang, Xujie Zhuang, Zeyu Cai, Wenjian Min, Xiao Wang, Yibei Xiao, Peng Yang
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer. Journal of medicinal chemistry 66 (6) (2023)
Haojie Dong, Xiuquan Ye, Yasheng Zhu, Hao Shen, Hongtao Shen, Weijiao Chen, Minghui Ji, Mingming Zheng, Keren Wang, Zeyu Cai, Haopeng Sun, Yibei Xiao, Peng Yang
Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC. Journal of medicinal chemistry (2023)
Kai Yuan, Fei Xia, Qiannan Li, Mingming Zheng, Hongtao Shen, Weijiao Chen, Huanaoyu Yang, Xujie Zhuang, Xiao-Yu Zhang, Yibei Xiao, Peng Yang
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer. Journal of medicinal chemistry (2023)
Kai Yuan, Zhaoxing Li, Wenbin Kuang, Xiao Wang, Minghui Ji, Weijiao Chen, Jiayu Ding, Jiaxing Li, Wenjian Min, Chengliang Sun, Xiuquan Ye, Meiling Lu, Liping Wang, Haixia Ge, Yuzhang Jiang, Haiping Hao, Yibei Xiao, Peng Yang
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer. Nature communications 13 (1) (2022)
Chengliang Sun, Mingxiao Yin, Yao Cheng, Zean Kuang, Xiaojia Liu, Gefei Wang, Xiao Wang, Kai Yuan, Wenjian Min, Jingwen Dong, Yi Hou, Lingrong Hu, Guoyu Zhang, Wenli Pei, Liping Wang, Yanze Sun, Xinmiao Yu, Yibei Xiao, Hongbin Deng, Peng Yang
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of medicinal chemistry 66 (3) (2022)
Chengliang Sun, Mingxiao Yin, Yao Cheng, Zean Kuang, Xiaojia Liu, Gefei Wang, Xiao Wang, Kai Yuan, Wenjian Min, Jingwen Dong, Yi Hou, Lingrong Hu, Guoyu Zhang, Wenli Pei, Liping Wang, Yanze Sun, Xinmiao Yu, Yibei Xiao, Hongbin Deng, Peng Yang
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of medicinal chemistry 66 (3) (2022)
Kai Yuan, Minghui Ji, Shengnan Xie, Zhixia Qiu, Weijiao Chen, Wenjian Min, Fei Xia, Mingming Zheng, Xiao Wang, Jiaxing Li, Yi Hou, Wenbin Kuang, Liping Wang, Wanjian Gu, Zhiyu Li, Peng Yang
Correction to "Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia". Journal of medicinal chemistry 65 (9) (2022)
Weijiao Chen, Minghui Ji, Hao Cheng, Mingming Zheng, Fei Xia, Wenjian Min, Huanaoyu Yang, Xiao Wang, Liping Wang, Li-Juan Cao, Kai Yuan, Peng Yang
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer. Journal of medicinal chemistry 65 (22) (2022)
Jiemei Li, Jing Niu, Wenjian Min, Jun Ai, Xu Lin, Jinhua Miao, Shan Zhou, Ye Liang, Shuangqin Chen, Qian Ren, Kunyu Shen, Qinyu Wu, Xiaolong Li, Weiwei Shen, Fan Fan Hou, Youhua Liu, Peng Yang, Lili Zhou
B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway. Cell death and differentiation (2022)
Xiao Wang, Wenbin Kuang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Hao Shen, Zhongrui Shi, Dawei Wang, Liping Wang, Peng Yang
Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Cancers 14 (15) (2022)
Yi Hou, Fang Zhang, Wenjian Min, Kai Yuan, Wenbin Kuang, Xiao Wang, Yasheng Zhu, Chengliang Sun, Fei Xia, Yanyin Wang, Haolin Zhang, Linping Wang, Peng Yang
Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. Journal of medicinal chemistry 65 (14) (2022)
Chengliang Sun, Mingxiao Yin, Yao Cheng, Zean Kuang, Xiaojia Liu, Gefei Wang, Xiao Wang, Kai Yuan, Wenjian Min, Jingwen Dong, Yi Hou, Lingrong Hu, Guoyu Zhang, Wenli Pei, Liping Wang, Yanze Sun, Xinmiao Yu, Yibei Xiao, Hongbin Deng, Peng Yang
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of medicinal chemistry (2022)
Chengliang Sun, Mingxiao Yin, Yao Cheng, Zean Kuang, Xiaojia Liu, Gefei Wang, Xiao Wang, Kai Yuan, Wenjian Min, Jingwen Dong, Yi Hou, Lingrong Hu, Guoyu Zhang, Wenli Pei, Liping Wang, Yanze Sun, Xinmiao Yu, Yibei Xiao, Hongbin Deng, Peng Yang
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of medicinal chemistry 66 (3) (2022)
Kai Yuan, Minghui Ji, Shengnan Xie, Zhixia Qiu, Weijiao Chen, Wenjian Min, Fei Xia, Mingming Zheng, Xiao Wang, Jiaxing Li, Yi Hou, Wenbin Kuang, Liping Wang, Wanjian Gu, Zhiyu Li, Peng Yang
Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia. Journal of medicinal chemistry 65 (1) (2021)
Yi Hou, Wenbin Kuang, Wenjian Min, Ziwen Liu, Fang Zhang, Kai Yuan, Xiao Wang, Chengliang Sun, Hao Cheng, Liping Wang, Yibei Xiao, Sheban Pu, Gui-Zhong Xin, Peng Yang
Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment. Journal of medicinal chemistry 64 (20) (2021)
Kai Yuan, Wenjian Min, Xiao Wang, Jiaxing Li, Wenbin Kuang, Fang Zhang, Shengnan Xie, Peng Yang
Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screening. Future medicinal chemistry 12 (12) (2020)

Peng Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peng Yang